期刊文献+

追踪监测脱氧吡啶啉诊断肺癌骨转移的意义 被引量:1

Track study in deoxypyridinoline on diagnose osseous metastasis of lung neoplasms
原文传递
导出
摘要 目的探讨尿脱氧吡啶啉(uDPD)对肺癌骨转移诊断的意义。方法 182例肺癌患者分骨转移组和未发现骨转移组,进行 uDPD/尿肌酐(uCr)比值、尿钙(uCa)/uCr、血清钙(sCa)、血清碱性磷酸酶(sAKP)比较,并对其在肺癌骨转移诊断的灵敏度、特异度作比较。同时,对其中80例肺癌未发现骨转移患者进行6个月的追踪观察。结果肺癌骨转移组 uDPD/Cr 为[(12.35±2.65)nmoL/mmo1],高于肺癌未发现骨转移组[(7.76±2.11)nmol/mmol,t=2.46,P<0.01];其诊断肺癌骨转移的灵敏度、特异度分别为81.4%和70%;80例肺癌无骨转移患者初测 uDPD/uCr 比值正常组6个月后骨转移率为17.4%,初测 uDPD/uCr 比值升高组6个月后骨转移率为55.9%;两组差异有统计学意义(X^2=12.95,P<0.01)。结论 uDPD 对肺癌骨转移诊断和与监测有较大临床意义。 Objective To explore the significance of urine deoxypyridinoline to diagnosis on osseous metastasis of lung neoplasms. Methods .182 cases with lung carcinoma was divided into two groups. One group was case with osseous metastasis, the other group was case without osseous metastasis, uDPD/uCr, uCa/Cr, sCa and sAKP in two groups were respectively compared. Sensitivity and specificity of these indexes to diagnosis on osseous metastasis of lung cancer were also acalculated and compared. 80 cases without osseous metastasis were follow-up for 6 months. Results The ratio of uDPD/uCr with osseous metastasis group [ (12. 35 ±2.65) nmol/mmol] was significantly higher than that of without osseous metastasis group [ ( 7. 76 ± 2. 11 ) nmol/mmol ] ( t = 2. 46, P 〈 0. 01 ). Sensitivity and specificity of uDPD/uCr to diagnosis on osseous metastasis of lung cancer were 81.4% and 70%, respectively. Osseous metastasis occurred in 17.4% of cases with normal uDPD/uCr but in 55.9% of cases with high uDPD/uCr the difference of occurrence of osseous metastasis between normal and higher uDPD/uCr was statistically significant (Χ^2 = 12.95 ,P 〈 0. 01 ). Conclusion uDPD has a significant impact on early diagnosis and surveillance on osseous metastasis of lung neoplasms.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2007年第7期767-769,共3页 Chinese Journal of Laboratory Medicine
关键词 肺肿瘤 肿瘤转移 脱氧吡啶啉 Lung neoplasms Neoplasms metastasis Deoxypryidinoline
  • 相关文献

参考文献11

  • 1de la Piedra C, Castro-Errecaborde NA, Traba ML, et al. Bone remodeling markers in the detection of bone metastases in prostate cancer. Clin Chim Acta, 2003,331 (1-2) : 45-53.
  • 2Alexandrakis MG, Passam FH, Malliarak iN, et al. Evaluation of bone disease in multiple myeloma: aeorrelation between biochem ical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Clin Chim Acta, 2002,325 (1-2) : 51-57.
  • 3Costa L, Demers LM, Gouveia-Oliveira A, et al. Prospective evaluation of the peptide-bound collagen type Ⅰ cross-links N- telopeptide and C-telopeptide in predicting bone metastases status. Clin Oncol, 2002,20: 850-856.
  • 4Coleman RE. Skeletal complications of malignancy. Cancer, 1997,80(8 suppl) : 1588-1594.
  • 5谢琳,任宏轩,李少莹,杨祚璋.肺癌骨转移120例临床分析[J].临床肺科杂志,2003,8(5):464-464. 被引量:8
  • 6Shih LY, Shih HN, Chen TH. Bone resorption activity of osteolytie metastatic lung and breast cancers. Orthop Res, 2004, 22: 1161-1167.
  • 7Chung JH, Park MS, Kim YS, et al. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer. Yonsei Med J, 2005,46:388-393.
  • 8Liubimova NV, Bronnikov IIU, Robins SP, et al. The biochemical markers of bone remodeling in cancer patients with skeletal involvement Vopr On kol, 2000,46:90-297.
  • 9Seibel MJ, Gartenberg F, Bilezikian JP, et al. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. Clin Endocrinol Metab, 1992,74:481-486.
  • 10Alatas F, Alatas O, Metintas M, et al. Usefuiness of bone markers for defection of bone metastases in lung cancer patiens. Clin Boichem, 2002, 35:293-296.

二级参考文献5

  • 1魏学立 叶广春 等.全身骨显像在骨肿瘤诊断上的应用[J].中华核医学杂志,1988,8(4):216-216.
  • 2Wilson MA,Calboun FM. The distrobution of skeletal metastases in breast and pulmonary cancer. Concise communication. Nucl Med,1981;22:594.
  • 3Kosuda S, Kaji T, Yokoyama H,et al. Does bone SPECT actually have lower sensitivity for detecting vertibra metastasis than MRI? J Nucl,1996,37(6):975-978.
  • 4曹来宾,王安明,徐爱德,何树岗,田维泽,江志勇,许祖闪,吴树森,王天保,陈宝仓,高士伟,王学庆,田军,孟凡录,李先启,庄悦新,秦东京,殷焕起,唐志学,臧宝江,唐桂长,崔华兴,徐万峰,李会祥,王国华,周海舟,周韶龙,衣建安.1047例骨转移瘤的影像学诊断[J].中华放射学杂志,1997,31(8):547-551. 被引量:102
  • 5洪淑芳,余爱平,文兵,张湘园.^(99m)T_c-MDP全身骨显像对转移性骨肿瘤的诊断价值(105例骨显像分析)[J].医学新知,1997,7(3):100-102. 被引量:5

共引文献7

同被引文献20

  • 1张骏,邓宏宇,巫刚.多发性骨髓瘤患者血钙异常的临床分析[J].中华血液学杂志,2005,26(4):246-247. 被引量:20
  • 2孔清泉,屠重棋,窦青瑜,汪金平,孙天威.骨转换生化指标在诊断原发性肺癌骨转移中的应用[J].四川大学学报(医学版),2005,36(3):397-399. 被引量:8
  • 3葛艳玲,张正.骨型碱性磷酸酶在骨肿瘤诊断中的价值[J].中华检验医学杂志,2006,29(2):136-139. 被引量:16
  • 4Chang MC, Chen JH, Liang JA, et al. Meta - analysis : compari- son of F - 18 florodeoxyglucose - positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer[J]. Acad Radiol, 2012, 19(3) : 349 -357.
  • 5Wang ZY, Yang C, Yang YM, et al. Clinical application value of bone turnover markers in non - small - cell lung cancer patients with bone metastases[J1. Chinese- German J Clin Oncol, 2011, 10(2) : 81 -84.
  • 6Wymenga LF, Boomsma JH, Groenier K, et al. Routine bone scans in patients with prostate cancer related to serum prostate spe- cific antigen and alkaline phosphatas[J]. BJU Int, 2001, 88(3) : 226 - 230.
  • 7Lipton A. Implications of bone metastases and the benefits of bone- targeted therapy[J]. Semin Oncol, 2010, 37(2) : S15 -$29.
  • 8Leeming D J, Koizumi M, Byrjalsen I, et al. The relative use of eight collagenous and noncollagenous markers for diagnosis of skele- tal metastases in breast, prostate, or lung cancer patients [ J ]. Cancer Epidemiol Biomarkers Prey, 2006, 15 ( 1 ) : 32 - 38.
  • 9Horiguchi T, Tachikawa S, Kondo R, et al. Usefulness of serum carboxy - terminal telopeptide of type I collagen (ICTP) as a mark- er of bone metastasis from lung cancer [ J ]. Jpn J Clin Oncol, 2000, 30(4) : 174 - 179.
  • 10Lnmachi F, Marino F, Fanti G, et al. Serum N - telopeptide of type I collagen and bone alkaline phosphatase and their relationship in patients with non - small cell lung carcinoma and bone metastases [J]. Anticancer Res, 2011, 31(11) : 3879 -3881.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部